Free Trial
→ My #1 Pre IPO Trade for 2025 – NAME and TICKER (From Wyatt Investment Research) (Ad) Free APLS Stock Alerts

Apellis Pharmaceuticals (APLS) ESG Score & Sustainability Data

Apellis Pharmaceuticals logo
$27.49 -1.50 (-5.17%)
(As of 11/20/2024 ET)
Compare

Key ESG Takeaways for Apellis Pharmaceuticals

The key takeaways are AI-generated and highlight the main contributors behind the net impact scores of Apellis Pharmaceuticals. The insights are based on millions of scientific articles, along with the company-specific product and service portfolio.
  • Apellis Pharmaceuticals seems to create the most significant positive value in categories , , and . The largest positive contribution comes from its impact, which is mostly driven by its Clinical research services for deficiency diseases, Pegcetacoplan, and Clinical research services for genetic diseases products.
  • Apellis Pharmaceuticals uses resources or causes negative impacts mostly in categories , , and . The negative contribution in the impact category seems to be driven mostly by its Pegcetacoplan, Clinical research services for genetic diseases, and Clinical research services for deficiency diseases products.
  • To improve its net impact, a company can either grow its positive impacts, or reduce its negative impacts. For example, by doubling its Preclinical research services for physical health business, Apellis Pharmaceuticals would improve its net impact ratio by 2 percentage points.

APLS Impact Ratio

Net impact ratio represents the net impact of a company. It is defined as the (positive impacts - negative impacts) / positive impacts. The maximum value for net impact ratio is 100%, representing a theoretical company with no negative impacts. The minimum value is -∞. Net scores depend on the value sets that determine the importance of different impact categories.
+67.3%
The default value set, where each category is given the same weight.

Value Sets Value sets can be used to assess how different stakeholder values or emphasis on certain values might affect the net impact ratio.

Millennials
Value set of millennials (b. 1980 - 1999), based on Upright's annual Impact at Work survey.
+72.2%
Most Wanted Workforce
Value set of the most wanted workforce, based on Upright's annual Impact at Work survey.
+60.5%
Society First
Value set that emphasizes society impacts over other impacts.
+28.1%
Knowledge First
Value set that emphasizes knowledge impacts over other impacts.
+84.1%
Health First
Value set that emphasizes health impacts over other impacts.
+81.0%

Apellis Pharmaceuticals ESG Score + Net Impact Profile

ImpactNegativeScorePositive
+1.45
+1.45
+1.71
+1.71
+0.04
+0.04
-0.02
-0.02
+0.00
-0.00
+0.09
+0.09
+0.00
+0.00
+2.85
+2.85
-0.00
+0.00
+0.00
-1.98
-1.98
-0.71
+4.75
+5.46
-0.05
+0.40
+0.45
0.00
+0.00
-0.00
+0.01
+0.01
-0.00
+0.32
+0.33
-0.71
-0.71
+0.00
-0.14
-0.14
+0.00
-0.02
-0.02
+0.00
-0.02
-0.02
+0.00
-0.39
-0.39
+0.00

Upright Model Version 0.6.0
ESG Data Last Updated: October 12, 2022

Ad Darwin
New Year, New Opportunity! 2 AI Stocks Under $10 Ready to Soar
As we step into 2025, artificial intelligence (AI) stocks continue to dominate headlines, and now is the perfect moment to position yourself for the coming year’s potential. Our latest research has uncovered two must-buy AI stocks currently trading under $10/share – an affordable entry with promising growth potential. These stocks are flying under the radar, but it’s only a matter of time before they gain mainstream attention.
👉 Click here to access your FREE report now!

About Upright's Net Impact Model

Upright Model

Upright's Net Impact Data quantifies the holistic value creation and impact of companies. It details both the negative and positive impacts a company has on the environment, health of people, society and knowledge, and forms a net sum of these costs and gains based on the economic costs of each impact category. The data is produced by Upright's Net Impact model, which is a mathematical model of the economy that produces continuously updated estimates of the net impact of companies by means of an information integration algorithm. The data is primarily sourced from the CORE open access database, which contains over 200 million scientific papers. Other sources of data include open databases published by the World Bank, IMF, WHO, OECD, IPCC, CDC and USDA.

Apellis Pharmaceuticals ESG Score - Frequently Asked Questions

How is Apellis Pharmaceuticals doing in terms of sustainability?

According to The Upright Project, which measures holistic value creation and impact of companies, Apellis Pharmaceuticals has a net impact ratio of 67.3%, indicating an overall positive sustainability impact. Apellis Pharmaceuticals seems to create the most significant positive value in the categories of Physical diseases, Creating knowledge, and Taxes. Apellis Pharmaceuticals uses resources or causes negative impacts mostly in the categories of Scarce human capital, GHG emissions, and Physical diseases. Learn more on the sustainability of Apellis Pharmaceuticals.


More ESG Stocks and Research Tools

Related Companies
Stock Lists
Sustainability Tools

This page (NASDAQ:APLS) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners
Missed Nvidia? Watch this ASAP
This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...
Brownstone Research | Sponsored
Musk’s new company could top a trillion?
The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...
Paradigm Press | Sponsored
Tim Sykes’ Urgent Trade Alert: “Make this move now”
WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...
Timothy Sykes | Sponsored
Unveiled: NVIDIA’s "Secret Royalty" Program
Did you know that there's an investment that will give you the opportunity to collect "royalties" every time N...
Behind the Markets | Sponsored
$2 Trillion Disappears Because of Fed's Secretive New Move
$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...
Stansberry Research | Sponsored
24/7 Automated Profits in Crypto
The 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...
Crypto Swap Profits | Sponsored
Trump Wins… But Elon Says Get Ready to Brace
Trump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...
Genesis Gold Group | Sponsored
But another coin could soar even higher …
Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...
Weiss Ratings | Sponsored